These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 12235103)

  • 1. Cancer therapy and renal injury.
    Schrier RW
    J Clin Invest; 2002 Sep; 110(6):743-5. PubMed ID: 12235103
    [No Abstract]   [Full Text] [Related]  

  • 2. Resveratrol attenuates acute kidney injury by inhibiting death receptor‑mediated apoptotic pathways in a cisplatin‑induced rat model.
    Hao Q; Xiao X; Zhen J; Feng J; Song C; Jiang B; Hu Z
    Mol Med Rep; 2016 Oct; 14(4):3683-9. PubMed ID: 27600998
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Porous Se@SiO2 nanospheres attenuate cisplatin-induced acute kidney injury via activation of Sirt1.
    Li X; Wang Q; Deng G; Liu Y; Wei B; Liu X; Bao W; Wang Q; Wu S
    Toxicol Appl Pharmacol; 2019 Oct; 380():114704. PubMed ID: 31400413
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cisplatin-induced nephrotoxicity is mediated by tumor necrosis factor-alpha produced by renal parenchymal cells.
    Zhang B; Ramesh G; Norbury CC; Reeves WB
    Kidney Int; 2007 Jul; 72(1):37-44. PubMed ID: 17396112
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Interstitial renal fibrosis due to multiple cisplatin treatments is ameliorated by semicarbazide-sensitive amine oxidase inhibition.
    Katagiri D; Hamasaki Y; Doi K; Negishi K; Sugaya T; Nangaku M; Noiri E
    Kidney Int; 2016 Feb; 89(2):374-85. PubMed ID: 26535996
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Paricalcitol prevents cisplatin-induced renal injury by suppressing apoptosis and proliferation.
    Park JW; Cho JW; Joo SY; Kim CS; Choi JS; Bae EH; Ma SK; Kim SH; Lee J; Kim SW
    Eur J Pharmacol; 2012 May; 683(1-3):301-9. PubMed ID: 22449373
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Carnosic acid attenuates renal injury in an experimental model of rat cisplatin-induced nephrotoxicity.
    Sahu BD; Rentam KK; Putcha UK; Kuncha M; Vegi GM; Sistla R
    Food Chem Toxicol; 2011 Dec; 49(12):3090-7. PubMed ID: 21930180
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Celecoxib, a selective cyclooxygenase-2 inhibitor, attenuates renal injury in a rat model of Cisplatin-induced nephrotoxicity.
    Suddek GM; El-Kenawi AE; Abdel-Aziz A; El-Kashef HA
    Chemotherapy; 2011; 57(4):321-6. PubMed ID: 21893983
    [TBL] [Abstract][Full Text] [Related]  

  • 9. TNFR2-mediated apoptosis and necrosis in cisplatin-induced acute renal failure.
    Ramesh G; Reeves WB
    Am J Physiol Renal Physiol; 2003 Oct; 285(4):F610-8. PubMed ID: 12865254
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tumor necrosis factor-alpha in cisplatin nephrotoxicity: a homebred foe?
    Dong Z; Atherton SS
    Kidney Int; 2007 Jul; 72(1):5-7. PubMed ID: 17597786
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Endotoxin and cisplatin synergistically induce renal dysfunction and cytokine production in mice.
    Ramesh G; Zhang B; Uematsu S; Akira S; Reeves WB
    Am J Physiol Renal Physiol; 2007 Jul; 293(1):F325-32. PubMed ID: 17494092
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Salubrinal, an eIF2α dephosphorylation inhibitor, enhances cisplatin-induced oxidative stress and nephrotoxicity in a mouse model.
    Wu CT; Sheu ML; Tsai KS; Chiang CK; Liu SH
    Free Radic Biol Med; 2011 Aug; 51(3):671-80. PubMed ID: 21616140
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Protective effect of intra-peritoneal epinephrine on postoperative renal function after cisplatin-based intra-peritoneal intra-operative chemotherapy.
    Pili-Floury S; Royer B; Bartholin F; Crumiere N; Combe M; Chalopin JM; Pivot X; Heyd B; Chauffert B; Samain E
    Eur J Obstet Gynecol Reprod Biol; 2011 Jun; 156(2):199-203. PubMed ID: 21306815
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Case of cisplatin induced acute renal failure].
    Mizumura Y; Matsumoto M; Takata M; Iida H; Sugimoto T
    Nihon Naika Gakkai Zasshi; 1983 Oct; 72(10):1426-31. PubMed ID: 6687126
    [No Abstract]   [Full Text] [Related]  

  • 15. Possible mechanisms for N-acetyl cysteine and taurine in ameliorating acute renal failure induced by cisplatin in rats.
    Shalby AB; Assaf N; Ahmed HH
    Toxicol Mech Methods; 2011 Sep; 21(7):538-46. PubMed ID: 21470069
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Anti-inflammatory role of tempol (4-hydroxy-2,2,6,6-tetramethylpiperidin-1-oxyl) in nephroprotection.
    Afjal MA; Abdi SH; Sharma S; Ahmad S; Fatima M; Dabeer S; Akhter J; Raisuddin S
    Hum Exp Toxicol; 2019 Jun; 38(6):713-723. PubMed ID: 30924375
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cisplatin nephrotoxicity: a review of the literature.
    Manohar S; Leung N
    J Nephrol; 2018 Feb; 31(1):15-25. PubMed ID: 28382507
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Acute renal failure induced by antimicrobial and antineoplastic agents].
    Nakahama H; Fukuhara Y; Orita Y
    Nihon Rinsho; 1991 Jun; 49(6):1323-7. PubMed ID: 1886218
    [No Abstract]   [Full Text] [Related]  

  • 19. Effect of elevated serum uric acid on cisplatin-induced acute renal failure.
    Roncal CA; Mu W; Croker B; Reungjui S; Ouyang X; Tabah-Fisch I; Johnson RJ; Ejaz AA
    Am J Physiol Renal Physiol; 2007 Jan; 292(1):F116-22. PubMed ID: 17210794
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Regulated necrosis and failed repair in cisplatin-induced chronic kidney disease.
    Landau SI; Guo X; Velazquez H; Torres R; Olson E; Garcia-Milian R; Moeckel GW; Desir GV; Safirstein R
    Kidney Int; 2019 Apr; 95(4):797-814. PubMed ID: 30904067
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.